Abstract:Background Transcription factor PU.1, a member of the ETS family, is a master regulator of myeloid differentiation whose functional disruption is often associated with acute myeloid leukemia (AML). Although much has been learned about PU.1 over the past decades, relatively little is known about cis -elements that interact with this factor under physiological or pathological conditions, especially in the whole-genome scale. We aimed to define the cistrome of PU.1 in acute promyelocytic leukemia (APL) cells and characterize the cis -elements bound by PU.1. Methods Chromatin immunoprecipitation with specific antibody coupled with deep sequencing (ChIP-seq) was used to investigate the in vivo PU.1 binding sites at the whole-genome scale in APL-derived NB4 cells. The ChIP-quantitative (q)-PCR and luciferase reporter assays were used to validate the binding events and trans -activity, respectively. Various computational analyses, including motif mining, evolutionary conservation analysis and functional enrichment analysis, were performed to characterize the cis -elements that interacted with PU.1. Results A total of 26,907 significantly enriched binding regions of PU.1 were identified under the false discovery rate 0.1% in NB4 cells. PU.1 bound to various types of genomic regions and acted as a promoter-enhancer dual binding transcription factor. Based on the sequence length and composition, two types of representative motifs were identified in PU.1 binding sites: a long and a short motif. The long motif, characterized by high sequence specificity and binding affinity, predominantly resided in the promoter-distal regions. In contrast, the short one, with strong evolutionary constraint, represented the primary PU.1 cis -elements in the promoter-proximal regions. Interestingly, the short one showed more preference to be correlated with the binding of other factors, especially PML/RARα. Moreover, genes targeted by both PU.1 and PML/RARα were significantly involved in categories associated with oncogenesis, hematopoiesis and the pathogenesis of acute myeloid leukemia. Conclusions Our results demonstrate that structurally differentiated cis -elements that interact with PU.1 are functionally distinguishable in APL, suggesting that the sequence diversity of cis -elements might be a critical mechanism by which cells interpret the genome, and contribute to distinct physiological and/or pathological function.

PU.1, a Novel Capase-3 Substrate, Partially Contributes to Chemotherapeutic Agents-Induced Apoptosis in Leukemic Cells

PU.1 supports TRAIL-induced cell death by inhibiting NF-κB-mediated cell survival and inducing DR5 expression

PU.1 negatively regulates tumorigenesis in non-small-cell lung cancer

PU.1 Can Regulate the ZNF300 Promoter in APL-derived Promyelocytes HL-60

PU.1 Affects Proliferation of the Human Acute Myeloid Leukemia U937 Cell Line by Directly Regulating MEIS1

Downregulation of ANP32B, a Novel Substrate of Caspase-3, Enhances Caspase-3 Activation and Apoptosis Induction in Myeloid Leukemic Cells

Is PU.1 a Dosage-Sensitive Regulator of Haemopoietic Lineage Commitment and Leukaemogenesis?

Down-regulation of hematopoiesis master regulator PU.1 via aberrant methylation in chronic myeloid leukemia

Caspase-9 Mediates Puma Activation in Ucn-01-Induced Apoptosis

Deficiency of Sumo-Specific Protease 1 Induces Arsenic Trioxide-Mediated Apoptosis by Regulating Xbp1 Activity in Human Acute Promyelocytic Leukemia

Protease Nexin 1 Induces Apoptosis of Prostate Tumor Cells Through Inhibition of X-Chromosome-Linked Inhibitor of Apoptosis Protein

[Down-Regulation of Transcription Factor PU.1 Via Abnormal Epigenetic Modification in Chronic Myeloid Leukemia].

Coordinated regulation of the immunoproteasome subunits by PML/RARα and PU.1 in acute promyelocytic leukemia

Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1

EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis.

Structurally differentiated cis -elements that interact with PU.1 are functionally distinguishable in acute promyelocytic leukemia

Caspase-3-resistant uncleavable form of acidic leucine-rich nuclear phosphoprotein 32B potentiates leukemic cell apoptosis.

Inactivation of PBX3 and HOXA9 by down-regulating H3K79 methylation represses NPM1-mutated leukemic cell survival.

Inhibition of USP1 enhances anticancer drugs-induced cancer cell death through downregulation of survivin and miR-216a-5p-mediated upregulation of DR5

PUMA, a potent killer with or without p53

Over-expression of Ubiquitin Carboxy Terminal Hydrolase-L1 Induces Apoptosis in Breast Cancer Cells.